{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:11:07Z","timestamp":1789639867573,"version":"4.0.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1872,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.virol.2008.03.002","type":"journal-article","created":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T09:30:37Z","timestamp":1207733437000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector"],"prefix":"10.1016","volume":"376","author":[{"given":"Sagar U.","family":"Kapadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.virol.2008.03.002_bib1","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.virol.2008.03.002_bib2","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virol.2008.03.002_bib3","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","volume":"80","author":"Daddario-DiCaprio","year":"2006","journal-title":"J. Virol."},{"issue":"9520","key":"10.1016\/j.virol.2008.03.002_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.virol.2008.03.002_bib5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.virol.2008.03.002_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2004.20.989","article-title":"Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes","volume":"20","author":"Egan","year":"2004","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"Pt 8","key":"10.1016\/j.virol.2008.03.002_bib7","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1099\/vir.0.80955-0","article-title":"Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein","volume":"86","author":"Fukushi","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.virol.2008.03.002_bib8","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.virol.2008.03.002_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.00005-06","article-title":"Emerging respiratory viruses: challenges and vaccine strategies","volume":"19","author":"Gillim-Ross","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"17","key":"10.1016\/j.virol.2008.03.002_bib10","doi-asserted-by":"crossref","first-page":"9007","DOI":"10.1128\/JVI.78.17.9007-9015.2004","article-title":"Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein","volume":"78","author":"Giroglou","year":"2004","journal-title":"J. Virol."},{"issue":"5643","key":"10.1016\/j.virol.2008.03.002_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.virol.2008.03.002_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(81)90143-4","article-title":"Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription","volume":"23","author":"Iverson","year":"1981","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.virol.2008.03.002_bib13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.virol.2008.03.002_bib14","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1128\/JVI.75.22.11079-11087.2001","article-title":"Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge","volume":"75","author":"Kahn","year":"2001","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2008.03.002_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2008.03.002_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/jvi.10.6.1231-1235.1972","article-title":"The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody","volume":"10","author":"Kelley","year":"1972","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.virol.2008.03.002_bib17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"39","key":"10.1016\/j.virol.2008.03.002_bib18","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.virol.2008.03.002_bib19","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virol.2008.03.002_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0042-6822(82)90126-X","article-title":"The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes","volume":"121","author":"Lefrancois","year":"1982","journal-title":"Virology"},{"issue":"6965","key":"10.1016\/j.virol.2008.03.002_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"5748","key":"10.1016\/j.virol.2008.03.002_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"issue":"5624","key":"10.1016\/j.virol.2008.03.002_bib23","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The Genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.virol.2008.03.002_bib24","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.1128\/JVI.78.19.10628-10635.2004","article-title":"Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2","volume":"78","author":"Moore","year":"2004","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virol.2008.03.002_bib25","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1128\/JVI.80.9.4447-4457.2006","article-title":"Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge","volume":"80","author":"Natuk","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2008.03.002_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"issue":"Pt 4","key":"10.1016\/j.virol.2008.03.002_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-82-4-821","article-title":"Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins","volume":"82","author":"Okuma","year":"2001","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2008.03.002_bib28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2006.08.010","article-title":"An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","volume":"25","author":"Palin","year":"2007","journal-title":"Vaccine"},{"issue":"12 Suppl","key":"10.1016\/j.virol.2008.03.002_bib29","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"issue":"21","key":"10.1016\/j.virol.2008.03.002_bib30","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.virol.2008.03.002_bib31","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.virol.2008.03.002_bib32","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1128\/JVI.79.24.15043-15053.2005","article-title":"A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals","volume":"79","author":"Ramsburg","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2008.03.002_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4269\/ajtmh.1987.36.177","article-title":"Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups","volume":"36","author":"Reif","year":"1987","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"17","key":"10.1016\/j.virol.2008.03.002_bib34","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1128\/JVI.76.17.8900-8909.2002","article-title":"Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease","volume":"76","author":"Reuter","year":"2002","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2008.03.002_bib35","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2008.03.002_bib36","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2008.03.002_bib37","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/JVI.78.6.3196-3199.2004","article-title":"Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein","volume":"78","author":"Roberts","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.virol.2008.03.002_bib38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"5624","key":"10.1016\/j.virol.2008.03.002_bib39","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.virol.2008.03.002_bib40","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/JVI.74.10.4652-4657.2000","article-title":"Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies","volume":"74","author":"Schlereth","year":"2000","journal-title":"J Virol"},{"issue":"Pt 8","key":"10.1016\/j.virol.2008.03.002_bib41","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1099\/vir.0.19050-0","article-title":"Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose","volume":"84","author":"Schlereth","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2008.03.002_bib42","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/jvi.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"Schnell","year":"1996","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.virol.2008.03.002_bib43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0092-8674(00)80350-5","article-title":"Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection","volume":"90","author":"Schnell","year":"1997","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.virol.2008.03.002_bib44","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/JVI.02525-06","article-title":"Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA","volume":"81","author":"Simon","year":"2007","journal-title":"J. Virol."},{"issue":"6982","key":"10.1016\/j.virol.2008.03.002_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682208001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:52:04Z","timestamp":1758585124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682208001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0042682208001736"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2008.03.002","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2008.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}